paracy 150 mg/ml solution for infusion (im/iv)
n/a; importer: amb hk enterprises inc.; distributor: cyden medicale trading inc - paracetamol - solution for infusion (im/iv) - 150 mg/ml
merocy 1 g powder for injection (im/iv)
n/a; importer: amb hk enterprises inc; distributor: cyden medicale trading inc. - meropenem (as trihydrate) - powder for injection (im/iv) - 1 g
nervamin capsule
totalcare pharma, inc.; distributor: zyden pharma - vitamin b-complex - capsule - formulation: each capsule contains thiamine mononitrate (vitamin b1) 300 mg pyridoxine hydrochloride (vitamin b.)100 mg cyanocobalamin (vitamin b12) 100 mg
zydefer 500 mg/230 mcg/2 mg/3 mcg capsule
euro-health care exponents, inc.; distributor: zyden pharma - multivitamins , iron - capsule - 500 mg/230 mcg/2 mg/3 mcg
cepiden 1g powder for injection (i.m./i.v.)
philrx pharma inc.; distributor: cyden medicale trading - cefepime as (hydrochloride) - powder for injection (i.m./i.v.) - 1g
febuxden 40 40 mg film-coated tablet
bliss pharma distribution and consultation; distributor: cyden medicale trading - febuxostat - film-coated tablet - 40 mg
febuxden 80 80 mg film-coated tablet
bliss pharma distribution and consultation; distributor: cyden medicale trading - febuxostat - film-coated tablet - 80 mg
methyden 1g powder for injection
n/a; importer: sanimed pharmaceuticals inc.; distributor: cyden medicale trading - methylprednisolone (as sodium succinate) - powder for injection - 1g
vancocy 500 mg powder for injection (iv)
n/a; importer: afree pharmaceutical distribution corp.; distributor: cyden medicale trading inc - vancomycin (as hydrochloride) - powder for injection (iv) - 500 mg
docetaxel accord
accord healthcare s.l.u. - docetaxel - head and neck neoplasms, carcinoma, non-small-cell lung, adenocarcinoma, prostatic neoplasms, breast neoplasms - antineoplastic agents, - breast cancerdocetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:operable node-positive breast cancer;operable node-negative breast cancer.for patients with operable node-negative breast cancer, adjuvant treatment should be restricted to patients eligible to receive chemotherapy according to internationally established criteria for primary therapy of early breast cancer.docetaxel accord in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.docetaxel accord monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.docetaxel accord in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer w